Fortrea Holdings (FTRE) Current Assets (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Current Assets came in at $923.6 million in Q2 2026, down 3.79% on a YoY basis from $960.0 million in Q2 2025, and up 4.78% quarter-over-quarter from $881.5 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Current Assets (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Current Assets for 5 consecutive years, with $923.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Assets fell 3.79% year-over-year to $923.6 million; the trailing twelve-month figure through Jun 2026 stood at $923.6 million (down 3.79% YoY), and the FY2025 full-year result was $897.2 million, down 5.38% from the prior year.
- Current Assets improved to $923.6 million in Q2 2026 per FTRE's latest filing, from $881.5 million in the prior quarter.
- Across five years, Current Assets topped out at $1.3 billion in Q3 2023 and bottomed at $881.5 million in Q1 2026.
- Historically, Current Assets has averaged $1.0 billion across 5 years, with a median of $954.1 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Current Assets fell 27.92% in 2024, then gained 8.14% in 2025.
- Over 5 years, Current Assets stood at $1.2 billion in 2022, then climbed by 0.31% to $1.3 billion in 2023, then dropped by 24.19% to $948.2 million in 2024, then decreased by 5.38% to $897.2 million in 2025, then rose by 2.94% to $923.6 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $923.6 million, $881.5 million, and $897.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 6.23 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 1.05 Bn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 1.53 Bn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 3.75 Bn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 923.60 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | 847.23 Mn |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 332.54 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 19.22 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 11.83 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | 3.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 923.60 Mn |
| Mar 31, 2026 | 881.50 Mn |
| Dec 31, 2025 | 897.20 Mn |
| Sep 30, 2025 | 918.50 Mn |
| Jun 30, 2025 | 960.00 Mn |
| Mar 31, 2025 | 970.30 Mn |
| Dec 31, 2024 | 948.20 Mn |
| Sep 30, 2024 | 936.90 Mn |
| Jun 30, 2024 | 887.70 Mn |
| Mar 31, 2024 | 1.20 Bn |
| Dec 31, 2023 | 1.25 Bn |
| Sep 30, 2023 | 1.26 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Dec 31, 2022 | 1.25 Bn |